Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%) Natco Pharma - Quaterly Results
Date: 12-08-2024
The June 2024 quarter revenue stood at Rs. 12369.00 millions, up 17.99% as compared to Rs. 10483.00 millions during the corresponding quarter last year.Profit after tax for the quarter ended June 2024 reported a huge growth of 56.99% to Rs. 6363.00 millions from Rs. 4053.00 millions.Operating profit surged to 8028.00 millions from the corresponding previous quarter of 5183.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202406 | 202306 | % Var | 202406 | 202306 | % Var | 202403 | 202303 | % Var | |
| Sales | 12369.00 | 10483.00 | 17.99 | 12369.00 | 10483.00 | 17.99 | 35689.00 | 23510.00 | 51.80 |
| Other Income | 398.00 | 146.00 | 172.60 | 398.00 | 146.00 | 172.60 | 1047.00 | 855.00 | 22.46 |
| PBIDT | 8028.00 | 5183.00 | 54.89 | 8028.00 | 5183.00 | 54.89 | 17417.00 | 9302.00 | 87.24 |
| Interest | 44.00 | 32.00 | 37.50 | 44.00 | 32.00 | 37.50 | 145.00 | 86.00 | 68.60 |
| PBDT | 7984.00 | 5151.00 | 55.00 | 7984.00 | 5151.00 | 55.00 | 17272.00 | 9216.00 | 87.41 |
| Depreciation | 404.00 | 399.00 | 1.25 | 404.00 | 399.00 | 1.25 | 1719.00 | 1509.00 | 13.92 |
| PBT | 7580.00 | 4752.00 | 59.51 | 7580.00 | 4752.00 | 59.51 | 15553.00 | 7707.00 | 101.80 |
| TAX | 1217.00 | 699.00 | 74.11 | 1217.00 | 699.00 | 74.11 | 2487.00 | 1336.00 | 86.15 |
| Deferred Tax | -107.00 | -139.00 | -23.02 | -107.00 | -139.00 | -23.02 | -361.00 | 5.00 | -7320.00 |
| PAT | 6363.00 | 4053.00 | 56.99 | 6363.00 | 4053.00 | 56.99 | 13066.00 | 6371.00 | 105.09 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 365.00 | -1.92 |
| PBIDTM(%) | 64.90 | 49.44 | 31.27 | 64.90 | 49.44 | 31.27 | 48.80 | 39.57 | 23.34 |